Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12 Items
Title  Creator  Group name  Publishing year 
[Molecular signatures in castration-resistant prostate cancers: An update] Houédé and Pourquier EquipeCG 2022-07-21
[Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France] Houédé et al. EquipeCG 2022-06-17
[Development of a therapeutic education program for prostate cancer patients undergoing new generation hormone therapy] Cuenant et al. EquipeCG 2022-05
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1 Matheux et al. EquipeCG 2021-07-20
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial Culine et al. EquipeCG 2021-12
BAG6 promotes PINK1 signaling pathway and is essential for mitophagy Ragimbeau et al. EquipeCG 2021-02
[Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine] Houédé and Milano EquipeCG May 2019
[Impacts of routine patient-reported-outcomes monitoring in oncology] Fiteni et al. EquipeCG Jul 19, 2018
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer Pulido et al. EquipeCG 02 17, 2018
Enterocolitis in Patients with Cancer Treated with Docetaxel Fiteni et al. EquipeCG 04 2018
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways Rouanne et al. EquipeCG Nov 2018
Radium 223 dichloride for prostate cancer treatment Deshayes et al. EquipeCG 2017
12 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés